Scrip
Novo Nordisk launches Victoza in US
18 February 2010
Asher Mullard
18 February 2010
Asher Mullard
asher.mullard@informa.com
Novo Nordisk has launched Victoza (liraglutide) in the US, making it the second GLP-1 analogue to be made available in both the US and the EU. It was approved by the US FDA only weeks ago for type 2 diabetes, but the agency did not endorse its use in the first-line setting (
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
